Alpha Cognition ACOG
Speculative long, microcap.
Story:
New Alzheimer drug with promising prospects. New product is since April available.
Fundamental data: not really available. Last quarter small revenue from the new product. But enough money after IPO to bring the new drug into the market.
Technical:
Multi week Breakout + consolidation on lower volume. Nice chart pattern. Near IPO price. Near all time high.
Only succesful if prodct is running. Can be volatile until next earning releas with (hopefully) good news.
Entry : ~9 $
Target: No limit ;-) but I excpect at least a double at 18.
Risk in high volatile price / breakdown to old levels..
Speculative long, microcap.
Story:
New Alzheimer drug with promising prospects. New product is since April available.
Fundamental data: not really available. Last quarter small revenue from the new product. But enough money after IPO to bring the new drug into the market.
Technical:
Multi week Breakout + consolidation on lower volume. Nice chart pattern. Near IPO price. Near all time high.
Only succesful if prodct is running. Can be volatile until next earning releas with (hopefully) good news.
Entry : ~9 $
Target: No limit ;-) but I excpect at least a double at 18.
Risk in high volatile price / breakdown to old levels..
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.